Hang toughThat the shareprice has held up (grosso modo) suggests strong inherent support. Assay release is vital for several reasons. a) Company is owed about quarter million dollars from CCE, an amount payable upon exploration expenditure report, including assays. Cash is not a problem at present for company given that there is about 1 million dollars in the bank, but expediting settlements such as the amount due from CCE is always convenient. b) negotiation with or for Spectrum is contingent on assays in so far strong results offers CIN a stronger negotiating hand. c) strong assays prior to the Cambridge Show would spur strong retailer and other interest at the show. While it is true fund and other professional interest is vital, there is a tendency to underestimate the power of retailer interest in shaping share value.
Lastly, those who hang tough until assay release will be richly rewarded.